fda glp-1 news november 2025 Receptor Agonists and vision risk GLP-1 receptor agonists and next-generation

A.PetrovaM

Mitochondria, as the major site of oxidative reactions, must maintain sufficient levels of GSH to perform protective and biosynthetic functions 2

Reconstruction of the hepatitis C virus epidemic in the US hemophilia population, 19401990

The key take away is that we found an association between GLP-1 use and breast cancer incidence, presenting author Elizabeth McDonald, MD, PhD, a professor of Radiology in the University of Pennsylvania Perelman School of Medicine and a practicing breast radiologist at Penns Abramson Cancer Center, told Medical News Today

95% CI, 0.53-0.69)

Key Takeaways You can stop GLP-1 medications without regaining weight, but it requires viewing them as a catalyst rather than a cure